There are many aspects to diagnostic quality assurance in surgical pathology, each with its own specific value. However, in the current era of cost containment, the beneficial aspects of rereviewing pathology slides must be weighed against the resistance of third-party payers to offer reimbursement. Although it is possible that some compromise can be reached, guidelines regarding the second opinion review must be established jointly by clinicians and pathologists. See also pages 2426–35.
No takes yet. Share an insight, caveat, or question.
Tomaszewski et al. (1999) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: